20-Oct-2026 19:41:25
APTUS PHARMA H1 FY27: NET PROFIT UP 191% AT ₹5.08 CR (YOY)
REVENUE UP 240% AT ₹48.92 CR (YOY) EBITDA UP 167% AT ₹7.89 CR (YOY) MARGINS AT 16.1% VS 20.5% (YOY)
Latest market headlines for APPL on Terminal.
20-Oct-2026 19:41:25
REVENUE UP 240% AT ₹48.92 CR (YOY) EBITDA UP 167% AT ₹7.89 CR (YOY) MARGINS AT 16.1% VS 20.5% (YOY)
20-Oct-2026 19:01:29
Revenue up 166% at ₹48.92 Cr (YOY); EBITDA at ₹7.68 Cr with margin ~15.7%. PAT up 191% at ₹5.07 Cr (YOY); EPS at ₹2.96 v ₹1.37 (YOY). Targets 46% geographic co…